Abivax SA

000407

Abivax SA

Abivax SA
Company Profile

Abivax SA

Paris, United States of America

About Abivax Our Mission Company History Our Leadership Contact Us Our Science Novel MOA Obefazimod
0Products
0People
0Events
0Locations

Overview

Company details and contact information.

About

Abivax is a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. Abivax is currently evaluating obefazimod in Phase 3 clinical trials for adults with moderately to severely active ulcerative colitis. Visit www.abivax.com.

Address
7-11 Boulevard Haussmann, Paris France 75009, United States of America